The reactions of the oligodendrocyte

Chin, S.S. -M. and Goldman, J.E. 1996. Glial inclusions in CNS degenerative diseases. J. Neiiropathol. Exp. Neurol. 55: 499–508.

Compston, D.A. S., Scolding, N. , Wren, D. and Noble, M. 1991. The pathogenesis of demyelinating disease-insights from cell biology. Trends Neurosci. 14: 175–182.

Dent, M.A. R., Sumi, Y. , Morris, R.J. and Seeley, P.J. 1993. Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain. Eur. J. Nenrosci. 5: 633–647.

Duncan, I.D. 1996. Glial cell transplantation and remyelination of the central nervous system. Neuropathol. Appl. Neurobiol. 22: 87–100.

Ehinger, B. , Zucker, C.L. , Bruun, A. and Adolph, A. 1994. In vivo staining of oligodendroglia in the rabbit retina. Glia 10: 40–48.

Franklin, R.J. , Bayley, S. A. , Milner, R. , ffrench-Constant, C. and Blakemore, W.F. 1995. Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter. Glia 13: 39–44.

Franklin, R.J. and Blakemore, W.F. 1995. Glial-cell transplantation and plasticity in the 0–2A lineage-implications for CNS repair. [Review]. Trends in Neurosciences 18: 151–156.

Lachapelle, F. , Duhamel-Clerin, E. , Gansmuller, A. , Baron-Van Evercooren, A. , Villarroya, H. and Gumpel, M. 1994. Transplanted transgenically marked oligodendrocytes survive, migrate and myelinate in the normal mouse brain as they do in the shiverer mouse brain. Eur J Neurosci 6: 814–824.

Lucchinetti, C.F. , Brack, W. , Rodriguez, M. and Lassmann, H. 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6: 259–274.

Ludwin, S.K. 1984. Proliferation of mature oligodendrocytes after trauma to the central nervous system. Nature 308: 274–275.

Ludwin, S.K. 1988. Remyelination in the central nervous system and the peripheral nervous system. Adv. Neurol. 47: 215–254.

Ludwin, S.K. 1995. Pathology of the Myelin Sheath. In: TJieAxon: Structure, Function and Pathophysiology, S.G. Waxman , J.D. Kocsis and P.K. Stys , eds. New York: Oxford University Press, pp. 412–437.

Ludwin, S.K. and Szuchet, S. 1993. Myelination by mature ovine oligodendrocytes in vivo and in vitro: evidence that different steps in the myelination process are independently controlled. Glia 8: 219–231.

MacMicking, J.D. , Willenborg, D.O. , Weidemann, M.J. , Rockett, K.A. and Cowden, W.B. 1992. Elevated secretion of nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176: 303–307.

Mclaurin, J. , D'Souza, S. , Stewart, J. , Blain, M. , Beaudet, A. , Nalbantoglu, J. and Antel, J.P. 1995. Effect of tumor necrosis factor a and b on human oligodendrocytes and neurons in culture. Int. J. Devl. Nearoscience 13: 369–381.

Miller, D.J. , Asakura, K. and Rodriguez, M. 1996. Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol. 6: 331–344.

Oka, A. , Belliveau, M.J. , Rosenberg, P.A. and Volpe, J.J. 1993. Vulnerability of oligodendroglia to glutamate-pharmacology, mechanisms, and prevention. J. Neurosci. 13: 1441–1453.

Ozawa, K. , Suchanek, G. , Breitschopf, H. , Bruck, W. , Budka, H. , Jellinger, K. and Lassmann, H. 1994. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311–1322.

Raine, C.S. , Hintzen, R. , Traugott, U. and Moore, G.R. 1988. Oligodendrocyte proliferation and enhanced CNS remyelination after therapeutic manipulation of chronic relapsing EAE. Ann. N. Y. Acad. Sci. 540: 712–714.

Rodriguez, M. , Scheithauer, B.W. , Forbes, G. and Kelly, P.J. 1993. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin. Proc. 68: 627–636.

Warrington, A.E. , Barbarese, E. and Pfeiffer, S.E. 1993. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J. Neurosci. Res. 34: 1–13.

Yao, D.L. , Liu, X. , Hudson, L.D. and Webster, H.D. 1995. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 92: 6190–6194.

Yong, V.W. , Dooley, N.P. and Noble, P.G. 1994. Protein kinase C in cultured adult human oligodendrocytes: a potential role for isoform alpha as a mediator of process outgrowth. J. Neurosci. Res. 39: 83–96.

Zajicek, J. , Wing, M. , Skepper, J. and Compston, A. 1995. Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system. Lab. Invest. 73: 128–138.